Integrity Alliance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Integrity Alliance's BMY Position: Q1 2026 in Review
Integrity Alliance reduced its Bristol-Myers Squibb (BMY) stake by 4.9% in Q1 2026, selling an estimated $108K and leaving 35,527 shares worth $2.15M. The position accounts for 0.08% of the portfolio, ranked #194.
Integrity Alliance first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Integrity Alliance held 35,527 shares of Bristol-Myers Squibb worth $2.15M as of Q1 2026.
- Integrity Alliance sold 1,849 Bristol-Myers Squibb shares in Q1 2026, an estimated $108K.
- Bristol-Myers Squibb made up 0.08% of Integrity Alliance's portfolio in Q1 2026, its #194 holding.
- Integrity Alliance first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.